CNTX Stock Analysis: Buy, Sell, or Hold?
CNTX - Context Therapeutics Inc. Common Stock
$2.54
-0.05 (-2.12%)
▼
5d:
-16.06%
30d:
+12.67%
90d:
+124.34%
WAIT
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 06, 2026
Get Alerted When CNTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CNTX is down 16.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CNTX is down 16.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CNTX is currently trading at $2.54, which is considered fair relative to its 30-day fair value range of $2.36 to $3.06.
Technical Outlook: Technically, CNTX is in a strong uptrend. The price is currently testing key support at $2.48. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.62 (+117.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CNTX is in a strong uptrend. The price is currently testing key support at $2.48. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.62 (+117.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$2.36 -
$3.06
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 117.2% below Wall St target ($5.62)
- WARNING: Recommendation downgraded due to -16.1% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.36 -
$3.06
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$2.48
Resistance Level
$3.33
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.60
Wall Street Target
$5.63
(+117.2%)
Share & Embed Analysis
Last updated: March 30, 2026 1:40 PM ET
Data refreshes hourly during market hours. Next update: 2:40 PM
Data refreshes hourly during market hours. Next update: 2:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 61 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 49 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$109 | 51 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 58 HOLD |
|
MRNA
Moderna Inc |
SELL
27 analysts |
$44 | 59 HOLD |
